Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 7Unknown 2Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Neoplasms 1Neoplasm Metastasis 1Hematologic Neoplasms 1Emergencies 1

Interventions

Morphine 7Fentanyl 5Radiotherapy 4Methadone 4Zoledronic Acid 3Tapentadol 2Ropivacaine 2Pregabalin 2Prednisone 2Ketamine 2Ibandronic Acid 2Hydromorphone 2Glutamine 2Cryotherapy 2Cryosurgery 2Bupivacaine 2Acupuncture Therapy 2Acetaminophen 2pegfilgrastim 1oxycodone naloxone combination 1naloxegol 1ixabepilone 1incobotulinumtoxinA 1imisopasem manganese 1cyclobenzaprine 1cabozantinib 1acetaminophen, aspirin, caffeine drug combination 1Zolpidem 1Surveys and Questionnaires 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pain × Hydromorphone × Clear all
NCT01812759 2021-06-29

Fentanyl for Breakthrough Pain in the Emergency Department

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 8 charts

Emergencies, Pain

NCT01648699 2013-10-11

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Janssen Pharmaceutica

Phase 4 Terminated
20 enrolled 9 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡